Neogen CORP Form 4 insider transactions

NEOGEN Director Aashima Gupta acquired 2,071 shares of common stock through the vesting and settlement of Restricted Stock Units.

NEOGEN Director Ronald D. Green converted 2,071 Restricted Stock Units into common stock on October 7, 2025, increasing his direct beneficial ownership to 14,852 shares.

NEOGEN Director Jeffrey D. Capello acquired 2,071 shares of common stock through the vesting and settlement of Restricted Stock Units.

NEOGEN Director James C. Borel converted 2,071 Restricted Stock Units into common stock on October 7, 2025, increasing his direct beneficial ownership to 92,545 shares.

NEOGEN Director William T. Boehm converted 2,071 Restricted Stock Units into common stock on October 7, 2025.

NEOGEN CEO John Edward Adent acquired 35,736 shares of common stock through the conversion of Restricted Stock Units at a price of $5.43 per share.

NEOGEN's Chief Operating Officer, Douglas Edward Jones, acquired 14,294 shares of common stock through the vesting of Restricted Stock Units, while also disposing of 4,160 shares for tax purposes.

NEOGEN's CFO, David H. Naemura, reported the vesting of restricted stock units and subsequent sale of shares for tax purposes.

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting of restricted stock units and subsequent stock transactions.

NEOGEN's Chief Accounting Officer, John Patrick Moylan, acquired 1,985 shares of common stock through RSU vesting and disposed of 593 shares for tax purposes.

NEOGEN's CFO, David H. Naemura, acquired 230,203 shares of common stock and 591,690 stock options, effective August 15, 2025, as part of compensation.

NEOGEN's Chief Legal Officer, Amy M. Rocklin, acquired 119,705 shares of common stock and 307,680 stock options as part of equity compensation.

NEOGEN's Chief Accounting Officer, John Patrick Moylan, acquired 18,416 shares of common stock and 47,336 derivative securities, likely options or RSUs, effective August 15, 2025.

NEOGEN CEO Mikheal Nassif reported the acquisition of over 2.1 million shares and derivative securities, including options and restricted stock units, through grants with future vesting schedules.

NEOGEN Corporation's Director, Andrea F. Wainer, acquired 6,090 shares of common stock and 16,303 derivative securities (options/RSUs) on June 2, 2025, signaling increased insider ownership.

NEOGEN's Chief Financial Officer, David H. Naemura, has reported the acquisition of 52,724 shares of common stock and 211,723 derivative securities (rights to buy common stock) at an exercise price of $5.69 per share, indicating a substantial increase in his beneficial ownership.

Amy M. Rocklin, Chief Legal Officer of NEOGEN CORP, reported the acquisition of 43,585 shares of common stock and 175,024 derivative securities, likely options or RSUs, on June 2, 2025, signaling increased insider ownership.

NEOGEN Corp.'s Chief Accounting Officer, John Patrick Moylan, has acquired 26,362 shares of common stock and 70,574 derivative securities, signaling confidence in the company's future.

Director Aashima Gupta purchased 16,000 shares of Neogen Corp common stock at $6.2492 per share on May 12, 2025.

John Patrick Moylan, Chief Accounting Officer of Neogen Corp, exercised stock options and sold shares on May 1, 2025.

Neogen CEO John Edward Adent exercised restricted stock units (RSUs) on April 28, 2025, converting them into common stock.

Douglas Edward Jones, Chief Operating Officer of Neogen Corp, reports the vesting and settlement of restricted stock units (RSUs) resulting in the acquisition and disposal of common stock.

Amy M. Rocklin, Chief Legal Officer of Neogen Corp, reports the vesting and settlement of restricted stock units (RSUs) into common stock on April 28, 2025.

Director Catherine E Woteki purchased 5,770 shares of Neogen Corp stock at $5.17 per share on April 25, 2025.

Director James C. Borel purchased 30,000 shares of Neogen Corp stock at $4.99 per share on April 24, 2025.

Director William T Boehm purchased 5,000 shares of Neogen Corp common stock at $5.235 per share on April 24, 2025, increasing his total holdings to 36,214 shares.

Director James C Borel purchased 35,000 shares of Neogen Corp common stock at $4.894 per share on April 24, 2025.

Amy M Rocklin, Chief Legal Officer of Neogen Corp, recently purchased 12,500 shares of common stock at $4.99 per share.

Jeffrey D. Capello, a director at Neogen Corp, purchased 20,712 shares of common stock at $4.8386 per share on April 22, 2025.

Director James P. Tobin of Neogen Corp. purchased 10,000 shares of common stock at $4.7268 per share on April 22, 2025.